Ftse Mib
38.522,97
0,27%
DAX
22.444,16
0,81%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
0,00%
Bitcoin
95.867,55
-0,42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioMarin Pharmaceutical Inc (BMRN) BioMarin Pharmaceutical Inc (BMRN) Notizie

BioMarin Pharmaceutical Inc

BMRN
69,50
1,25 (1,83%)
Pre Mercato
Ultimo aggiornamento: 13:39:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/2/202522:07EDGAR2Form 8-K - Current report
19/2/202522:05PRNUSBioMarin Reports Fourth Quarter and Full Year 2024 Results;..
13/2/202520:14EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
05/2/202515:00PRNUSBioMarin to Host Fourth Quarter and Full-Year 2024 Financial..
13/1/202518:00PRNUSBioMarin Announces Legal Action Against Ascendis Pharma A/S..
06/1/202514:30PRNUSBioMarin to Present at the 43rd Annual J.P. Morgan..
04/12/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202416:45PRNUSBioMarin Presents Real-World Evidence Further Supporting..
14/11/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202420:27EDGAR2Form 144 - Report of proposed sale of securities
06/11/202414:00PRNUSBioMarin to Participate in Three Upcoming Investor..
31/10/202420:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202421:04EDGAR2Form 8-K - Current report
29/10/202421:03PRNUSBioMarin Announces 28% Y/Y Total Revenue Growth in the Third..
24/10/202413:00GLOBEMonopar Announces Agreement with Alexion, AstraZeneca Rare..
16/10/202414:30PRNUSBioMarin to Host Third Quarter 2024 Financial Results..
01/10/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/9/202422:29EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
24/9/202414:31EDGAR2Form 8-K - Current report
18/9/202414:00PRNUSBioMarin to Present Data Underscoring Sustained Positive..
17/9/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202419:00PRNUSBioMarin Holds Investor Day; Provides New Corporate Strategy..
04/9/202418:52EDGAR2Form 8-K - Current report
04/9/202413:30PRNUSBioMarin to Host Investor Day Today at 10:30 a.m. Eastern..
29/8/202414:00PRNUSBioMarin to Present at the 22nd Annual Morgan Stanley Global..
28/8/202423:02EDGAR2Form 8-K - Current report
22/8/202423:00EDGAR2Form 8-K - Current report
21/8/202414:30PRNUSBioMarin Announces New R&D and Business Development..
19/8/202415:00PRNUSBioMarin to Host 2024 Investor Day on September 4th in New..
15/8/202421:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202417:48EDGAR2Form 144 - Report of proposed sale of securities
05/8/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202422:05EDGAR2Form 8-K - Current report
05/8/202422:03PRNUSBioMarin Announces 20% Y/Y Total Revenue Growth in the..
05/8/202422:01PRNUSBioMarin Announces Updated Strategy for ROCTAVIAN® to Focus..
24/7/202422:05PRNUSU.S. Food and Drug Administration Approves BioMarin's..
23/7/202414:00PRNUSBioMarin to Host Second Quarter 2024 Financial Results..
17/6/202414:30PRNUSBioMarin to Present Data Highlighting Significant Impact of..
08/6/202400:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
07/6/202415:00PRNUSBioMarin Presents New Phase 3, Four-Year Data Underscoring..
05/6/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202416:18EDGAR2Form 144 - Report of proposed sale of securities
01/6/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202416:49EDGAR2Form 144 - Report of proposed sale of securities
31/5/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202420:22EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:18EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:10EDGAR2Form 144 - Report of proposed sale of securities
29/5/202416:28EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 68,25

La tua Cronologia

NASDAQ
BMRN
BioMarin Pharmaceutical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci